Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

One year after being acquired by Global Alzheimer’s Platform Innovations, Tampa-based Axiom Brain Health has expanded its ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.